Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis

Wenge Li, Tin Oo Khor, Changjiang Xu, Guoxiang Shen, Woo Sik Jeong, Siwang Yu, Ah Ng Kong

Research output: Contribution to journalArticle

422 Citations (Scopus)

Abstract

Oxidative stress has been implicated in the etiology of neurodegenerative disease, cancer and aging. Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases. We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis. Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes. We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was associated with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers. These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways. In addition, in vivo and in vitro data generated from our laboratory suggest that many dietary compounds can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged. In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways. Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.

Original languageEnglish (US)
Pages (from-to)1485-1489
Number of pages5
JournalBiochemical Pharmacology
Volume76
Issue number11
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Oxidative stress
Oxidative Stress
Antioxidants
Chemical activation
Apoptosis
Dextran Sulfate
Colitis
Antioxidant Response Elements
Neurodegenerative diseases
Reactive Nitrogen Species
Leucine Zippers
Biomarkers
Enzymes
Neurodegenerative Diseases
Oxidation-Reduction
Machinery
Colorectal Neoplasms
Reactive Oxygen Species
Carcinogenesis
Anti-Inflammatory Agents

Keywords

  • AOM
  • Apoptosis
  • DSS
  • NFκB
  • Nrf2

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. / Li, Wenge; Khor, Tin Oo; Xu, Changjiang; Shen, Guoxiang; Jeong, Woo Sik; Yu, Siwang; Kong, Ah Ng.

In: Biochemical Pharmacology, Vol. 76, No. 11, 01.12.2008, p. 1485-1489.

Research output: Contribution to journalArticle

Li, Wenge ; Khor, Tin Oo ; Xu, Changjiang ; Shen, Guoxiang ; Jeong, Woo Sik ; Yu, Siwang ; Kong, Ah Ng. / Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. In: Biochemical Pharmacology. 2008 ; Vol. 76, No. 11. pp. 1485-1489.
@article{85cb1c7e0ee84bd8a7c4228168b90138,
title = "Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis",
abstract = "Oxidative stress has been implicated in the etiology of neurodegenerative disease, cancer and aging. Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases. We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis. Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes. We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was associated with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers. These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways. In addition, in vivo and in vitro data generated from our laboratory suggest that many dietary compounds can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged. In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways. Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.",
keywords = "AOM, Apoptosis, DSS, NFκB, Nrf2",
author = "Wenge Li and Khor, {Tin Oo} and Changjiang Xu and Guoxiang Shen and Jeong, {Woo Sik} and Siwang Yu and Kong, {Ah Ng}",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.bcp.2008.07.017",
language = "English (US)",
volume = "76",
pages = "1485--1489",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis

AU - Li, Wenge

AU - Khor, Tin Oo

AU - Xu, Changjiang

AU - Shen, Guoxiang

AU - Jeong, Woo Sik

AU - Yu, Siwang

AU - Kong, Ah Ng

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Oxidative stress has been implicated in the etiology of neurodegenerative disease, cancer and aging. Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases. We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis. Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes. We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was associated with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers. These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways. In addition, in vivo and in vitro data generated from our laboratory suggest that many dietary compounds can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged. In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways. Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.

AB - Oxidative stress has been implicated in the etiology of neurodegenerative disease, cancer and aging. Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases. We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis. Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes. We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was associated with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers. These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways. In addition, in vivo and in vitro data generated from our laboratory suggest that many dietary compounds can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged. In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways. Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.

KW - AOM

KW - Apoptosis

KW - DSS

KW - NFκB

KW - Nrf2

UR - http://www.scopus.com/inward/record.url?scp=55949120110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949120110&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2008.07.017

DO - 10.1016/j.bcp.2008.07.017

M3 - Article

C2 - 18694732

AN - SCOPUS:55949120110

VL - 76

SP - 1485

EP - 1489

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 11

ER -